SUMMARY / ABSTRACT
Background Acid reflux episodes that extend to the proximal esophagus are more likely to be perceived. This suggests that the proximal esophagus is more sensitive to acid than the distal esophagus, which could be caused by impaired mucosal integrity in the proximal esophagus.
Our aim was to explore sensitivity to acid and mucosal integrity in different segments of the esophagus.
Methods A prospective observational study, including 12 patients with gastroesophageal reflux disease. After stopping acid secretion-inhibiting medication, two procedures were performed: an acid perfusion test and an upper endoscopy with electrical tissue impedance spectroscopy and esophageal biopsies. Proximal and distal sensitivity to acid and tissue impedance were measured in vivo, and mucosal permeability and epithelial intercellular spaces at different esophageal levels were measured in vitro.
Results Mean lag time to heartburn perception was much shorter after proximal acid perfusion (0.8 minutes) than after distal acid perfusion (3.9 minutes); p = 0.02. Median in vivo tissue impedance was significantly lower in the distal esophagus (4563 Ω·m) compared to the proximal esophagus (8170 Ω·m); p = 0.002. Transepithelial permeability, as measured by the median fluorescein flux was significantly higher in the distal (2051 nmol/cm 2 /h) than in the proximal segment (368 nmol/cm 2 /h); p = 0.033. Intercellular space ratio and maximum heartburn intensity were not significantly different between the proximal and distal esophagus.
Conclusion
In GERD patients off acid secretion-inhibiting medication, acid exposure in the proximal segment of the esophagus provokes symptoms earlier than acid exposure in the distal esophagus, whereas mucosal integrity is impaired more in the distal esophagus. These findings indicate that the enhanced sensitivity to proximal reflux episodes is not explained by increased mucosal permeability. GERD patients more often have reflux episodes reaching the proximal part of the esophagus than asymptomatic controls. (4, 6, 27) In both controls and GERD patients, proximal reflux generates symptoms more readily than reflux that only reaches the distal esophagus. (6, 9, 17) Even during proton pump inhibitor (PPI) treatment, which leads to reflux that is less acidic, proximal reflux episodes are more often associated with symptoms. (23, 31) Based on this evidence, the proximal segment of the esophagus seems to be more sensitive to exposure to gastric content than the distal segment. In the current study we aim to investigate the underlying mechanisms through which gastroesophageal reflux causes symptoms.
Keywords
Our hypothesis was that the higher acid sensitivity of the proximal part of the esophagus of GERD patients, as compared to the distal esophagus, is due to a more pronounced impairment in mucosal integrity in the proximal part. If this would be the case, then future therapy could be directed at protection of the mucosa. For this reason, we evaluated the acid sensitivity and the mucosal integrity of the proximal and distal segments separately in patients with GERD.
METHODS

Study subjects
This prospective, observational study was conducted in the Academic Medical Center, Amsterdam, the Netherlands. We included patients > 18 years old, with heartburn lasting more than 12 months, and gastroesophageal reflux disease confirmed by a positive symptom association probability (SAP) > 95% between reflux-specific symptoms and acidic reflux episodes on ambulatory pH-impedance measurement.(28) Patients were recruited at the outpatient clinic of the Motility Center of our hospital. None of the patients had peptic ulcer disease, Barrett's esophagus, history of gastrointestinal cancer or history of upper gastrointestinal tract surgery. All patients gave written informed consent and the study was approved by the Medical Ethics Committee of our hospital.
Sample size
We based our sample size on a previous pilot study by Niemantsverdriet et al. with a similar protocol in healthy volunteers. (17) In their study in 12 subjects they found significantly higher pain scores after proximal esophageal acid perfusion (mean 6.5) compared to distal esophageal perfusion (mean 3.6). When using the measured mean pain scores with the combined standard deviation of 3.1 and a paired 2-sided t-test with a significance level of 5% and a power of 80%, the sample size required to measure a difference in our patient group was 11. To ensure enough power, we included 12 patients.
Study protocol
Patients on PPIs, H 2 -receptor antagonists or prokinetic drugs underwent a 10-day pharmacological washout before upper endoscopy because these drugs can mask the effect of acid reflux on esophageal mucosa and can reverse the presence of dilated intercellular spaces (DIS) in the mucosa. (5) For the reduction of severe symptoms, patients were allowed to take rescue medication in the form of antacids. After 7 days of pharmacological washout, patients were asked to fill out the reflux disease questionnaire (RDQ) before an acid perfusion test was performed. Three days later, an upper endoscopy was performed. The RDQ is a 12-item questionnaire assessing the current severity and frequency of 3 GERD-related symptom domains (heartburn, regurgitation and epigastric pain). Each domain is assessed by four questions, all rated on a 5-point Likert scale. The mean RDQ scores thus range from 0 to 5.
This questionnaire was translated into Dutch and validated.(1)
Acid perfusion test -Acid sensitivity
Patients underwent an acid perfusion test, according to a previously described protocol.(2, 13)
A water-perfused manometry catheter was transnasally placed in the esophagus, with 2 infusion channels at 3 and 18 cm above the lower esophageal sphincter (LES). Through these channels, we perfused hydrochloric acid solution (0.1 N HCl, pH 1) or normal saline (0.9% NaCl, pH 6.5). After a 5-min adaptation period, each segment of the esophagus was perfused for 10 minutes with either a HCl or NaCl solution first and then with the other solution, at a rate of 2.5 ml/min. The sequence of the 4 perfusion periods was randomly assigned and patients were blinded to the nature of the infused solution. During HCl infusion via the proximal channel, bicarbonate (1.4% HCO 3 -) was infused through the distal channel, to neutralize the acid in the distal segment. Simultaneous pH monitoring with a catheter with pH electrodes at the infusion sites, ensured that a pH < 4 was achieved at the HCl infusion site and a pH > 4 at the other segment. (17) During the test, subjects were asked to score the symptom intensity every 2 minutes on a horizontal 100-mm visual analogue scale (VAS) with the extremes labelled 'no pain' and 'worst possible pain'. Furthermore, they were asked to report the first sensation of heartburn, discomfort and pain. When subjects experienced pain, acid infusion was discontinued immediately. The lag time from the start of acid infusion to initial discomfort and the maximum VAS score during acid perfusion were noted. Combining both parameters, the perfusion sensitivity score (PSS) was calculated as (total acid perfusion time -lag time to perception) · maximum VAS. (12) Upper endoscopy
In each patient, after 10 days of pharmacological washout, an upper endoscopy was performed by one and the same gastroenterologist. After routine inspection of the esophagus, stomach and proximal duodenum, Electrical Tissue Impedance Spectroscopy (ETIS) measurements were performed at 3 cm and 18 cm proximal to the Z-line. Additionally, at each level 5 large mucosal biopsies were obtained with a jumbo biopsy forceps. (14) These biopsies were used to investigate the mucosal permeability in Ussing chambers, and to measure dilation of intercellular spaces using transmission electron microscopy. All biopsies were taken from macroscopically unaffected mucosa.
Electrical tissue impedance spectroscopy -In vivo mucosal integrity
Electrical tissue impedance spectroscopy (ETIS) measurements were performed at two levels, in a 4-quadrant fashion, using a dedicated probe (diameter 2. 
Transmission Electron Microscopy -In vitro mucosal integrity
Intercellular space between epithelial cells in the basal epithelial layers is considered a measure of mucosal integrity.(5, 22) Two mucosal biopsies, taken at 3 cm and 18 cm above the LES, were immediately immersed in Karnovsky fixative. After storage at 4° Celsius for several days, tissues were post-fixed, block-stained, dehydrated and embedded in epoxy resin.
With a Philips CM10 transmission electron microscope (FEI Technai G2 Spirit), the laboratory technician, blinded to the status of the biopsy, took 10 random photographs of each biopsy at the basal layer (magnification 4600x), using a digital transmission EM camera.
Dedicated software was used (Qwin, Leica Microsystems, Wetzlar, Germany) to calculate the intercellular space ratio by dividing the intercellular space surface by the total cell surface
(figure 2).(26)
Statistical analyses
We performed all analyses using SPSS Statistics version 22.0 and Graph Pad Prism version 5.0. Normally distributed data are described as number and percentage or mean with range when appropriate. Not normally distributed data are described as median with interquartile range (IQR) or range when appropriate. Lag time to initial heartburn perception was analyzed using survival curves and the log rank (Mantel-Cox) test. Symptom intensity, perfusion sensitivity scores, and intercellular space ratio were compared using the Wilcoxon signed rank test (paired samples). The multiple related measurements obtained for each individual subject with the ETIS probe and with the Ussing experiments were analyzed by calculating a median of the multiple measurements, followed by the Wilcoxon signed rank test (paired samples). A p-value < 0.05 was considered significant.
RESULTS
Subject characteristics
We included 12 GERD patients (8 females), with a mean age of 49 years (range 28 -66 years). The mean RDQ score was 3.4 out of 5. Seventy-five percent of patients reported that they had daily heartburn and regurgitation. Median (IQR) acid exposure time, as measured with 24-hour pH-impedance monitoring off PPI, was 9.7% (8.4 -14.3%). Median number of reflux events was 134 (IQR 93 -162). All patients had a symptom association probability (SAP) > 95% for acidic reflux episodes. All patients used PPIs and discontinued PPI use.
Esophageal acid sensitivity
In all patients, the esophageal acid sensitivity test was successfully performed (figure 3). Two In four samples the basal membrane could not be identified in the specimen, hampering orientation and therefore these biopsies were not used for assessment of intercellular space ratio.
DISCUSSION
In the present study we demonstrated that in GERD patients the threshold for induction of heartburn by intraesophageal acid perfusion was lower in the proximal than in the distal segment of the esophagus, while mucosal integrity was more impaired in the distal than in the proximal esophageal segment.
Several previous studies have shown that reflux reaching the proximal esophagus is more likely to provoke symptoms than distal reflux, in both GERD patients and controls. (6, 9, 11, 17) In addition, it has been found that GERD patients have a higher proximal esophageal acid exposure and longer duration of proximal reflux events than healthy controls(4, 6, 27) and that PPI-refractory GERD is associated with more proximal reflux episodes. (19, 23, 31) Understanding of the mechanisms that underlie the enhanced proximal sensitivity could lead to improvement of GERD treatment. The current study was the first combining the measurement of acid sensitivity and mucosal integrity in the proximal and distal segment separately, in an attempt to explain the underlying mechanism of enhanced sensitivity of proximal reflux.
We hypothesized that GERD patients would be more sensitive to proximal than distal acid perfusion due to more pronounced mucosal integrity changes in the proximal esophagus.
Although we confirmed the presence of increased sensitivity to acid at the proximal segment, the mucosa was actually more impaired distally.
From our results, we conclude that the enhanced perception of proximal reflux that is frequently present in patients with GERD cannot be attributed to increased mucosal permeability in the proximal esophagus. Moreover, we think that the enhanced proximal sensitivity is not likely to be due to a larger reflux volume or a lower pH-drop, causing a stronger trigger for exposed nociceptors, as previously suggested. (11, 21) Our results demonstrate that infusion of small volumes of acid in the proximal esophagus lead to faster perception than infusion of similar volumes of acid in the distal esophagus. In our opinion, this makes it less likely that a larger reflux volume is underlying the faster perception of acid in the proximal esophagus. However, it should be noticed that in our study the proximal acid infusion area (3 to 18 centimeters above the LES) is larger than the distal infusion area (3 centimeters above the LES), even though we buffered the distal area during proximal acid infusion. This means that a larger exposed esophageal area or delayed acid clearance can still be a possible explanation for increased sensitivity in the proximal esophagus, but this is also the case in the esophagus after a reflux episode. (3) The results of a recent study suggest that the mucosal afferent nerves are located more superficially than in the distal esophagus. This feature also can be a possible explanation for the observed enhanced sensitivity to acid of the proximal esophagus. (29) In the current study, we confirmed that, in patients with GERD, mucosal integrity in the distal esophagus is impaired. Only one previous study compared this to the mucosal integrity of the proximal esophagus, in healthy volunteers. (29) We found that the mucosal integrity in the distal esophagus was lower than in the proximal esophagus, which is consistent with their results of a lower baseline impedance and a trend towards a lower TEER in the distal than the proximal esophagus. (29) It is tempting to explain the isolated distal mucosal impairment by the fact that the distal segment is exposed to acid reflux more frequently and for longer Our patients were allowed to take rescue medication in the form of antacids. It is possible that this may have reduced the abnormalities in mucosal permeability. However, no conclusive literature was found regarding the effect of antacids on esophageal mucosal healing.
Moreover, prohibiting antacids could introduce selection bias and raise ethical concerns.
Based on these methodological objections and the pharmacodynamics, we chose to allow antacid use. (7) In conclusion, the findings of this study show that, in GERD patients, acid exposure in the proximal esophagus provokes symptoms earlier than acid exposure in the distal esophagus, whereas mucosal integrity is impaired more in the distal esophagus. These observations indicate that the enhanced sensitivity to proximal reflux episodes, characteristic of GERD, cannot be explained by increased permeability of the mucosa in the proximal esophagus. 
